These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 5875714)
1. United Kingdom Committee on safety of drugs. Pharmakotherapia; 1964; 2(1):207. PubMed ID: 5875714 [No Abstract] [Full Text] [Related]
2. AN INTERNATIONAL DRUG SAFETY PROGRAM. FINNEY DJ J New Drugs; 1963; 3(5):262-5. PubMed ID: 14089801 [No Abstract] [Full Text] [Related]
3. WASHINGTON AND NEW DRUGS. NEW REGULATIONS REQUIRE FILING OF SAFETY AND EFFICACY DATA FOR NEW DRUGS INTRODUCED SINCE 1938. LARRICK GP J New Drugs; 1964; 4(2):105-10. PubMed ID: 14197104 [No Abstract] [Full Text] [Related]
4. Problems relating to investigational drugs. Kelsey O Pharmakotherapia; 1964; 2(1):208-12. PubMed ID: 5875715 [No Abstract] [Full Text] [Related]
5. [DRUG LAWS IN THE GERMAN DEMOCRATIC REPUBLIC]. RUCKPAUL K; STOPP G Dtsch Gesundheitsw; 1964 Jun; 19():1126-8. PubMed ID: 14233023 [No Abstract] [Full Text] [Related]
6. Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom. Cahal DA Can Med Assoc J; 1968 Feb; 98(6):271-5. PubMed ID: 5636096 [No Abstract] [Full Text] [Related]
7. NEW DRUG SURVEILLANCE IN 1964. ELLENHORN MJ Am J Pharm Sci Support Public Health; 1964; 136():114-27. PubMed ID: 14167236 [No Abstract] [Full Text] [Related]
9. [Communication of the board of directors of the Pharmacological Society and the commission drawing up directions for testing of new drugs]. Pharmakotherapia; 1964; 2(1):195-207. PubMed ID: 5875713 [No Abstract] [Full Text] [Related]
10. THE USEFULNESS OF USELESS KNOWLEDGE. MODELL W Clin Pharmacol Ther; 1964; 5():145-8. PubMed ID: 14155154 [No Abstract] [Full Text] [Related]
11. The role of the Committee on Safety of Drugs. Mansel-Jones D Br Med Bull; 1970 Sep; 26(3):257-9. PubMed ID: 4922462 [No Abstract] [Full Text] [Related]
12. Compound names for drugs. Drug Ther Bull; 1970 Jan; 8(3):9-10. PubMed ID: 5417899 [No Abstract] [Full Text] [Related]
14. Design, development and decline of a medicine. Report of a conference. Wells F J R Coll Physicians Lond; 1990 Oct; 24(4):298-303. PubMed ID: 2258847 [No Abstract] [Full Text] [Related]
15. International Symposium on Clinical Pharmacology. Introduction. Smahel O Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):3-5. PubMed ID: 4924327 [No Abstract] [Full Text] [Related]
16. PROPORTIONATE COSTS OF DRUG TESTING IN ANIMALS. BONFIELD CT Lab Anim Care; 1964 Oct; 14():404-8. PubMed ID: 14212342 [No Abstract] [Full Text] [Related]
17. The development of a new drug in a pharmaceutical firm. Preclinical investigation of drugs. Paget GE Adv Sci; 1967 Feb; 23(116):502-8. PubMed ID: 6044856 [No Abstract] [Full Text] [Related]
18. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries]. Burow W; Lüllmann H Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578 [No Abstract] [Full Text] [Related]
19. The british pharmaceutical industry: 1868-1968. Lumley JA Practitioner; 1968 Jul; 201(201):217-23. PubMed ID: 4873111 [No Abstract] [Full Text] [Related]
20. Control of drugs. Br Med J; 1967 Sep; 3(5567):689-90. PubMed ID: 6038356 [No Abstract] [Full Text] [Related] [Next] [New Search]